# Illumina, Inc.: financial statements, quarterly

ILMN · Nasdaq · CIK 1110803 · [Technology](/sectors/technology.md) · fiscal year ends Jan 3

Pages: [Overview](/companies/ilmn.md) · [Financials](/companies/ilmn/financials.md) · [Filings](/companies/ilmn/filings.md) · [Insiders](/companies/ilmn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ilmn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,119](/filings/0001110803-24-000052.md) | [1,122 d](/filings/0001110803-26-000024.md) | [1,076](/filings/0001110803-25-000046.md) | [1,112](/filings/0001110803-25-000060.md) | [1,080](/filings/0001110803-25-000073.md) | [1,104 d](/filings/0001110803-26-000024.md) | [1,041](/filings/0001110803-26-000092.md) | [1,059](/filings/0001110803-26-000160.md) | [1,084](/filings/0001110803-25-000073.md) | [1,159 d](/filings/0001110803-26-000024.md) | [1,091](/filings/0001110803-26-000092.md) | [1,159](/filings/0001110803-26-000160.md) |
| Cost of revenue | $m | [435](/filings/0001110803-24-000052.md) | [448 d](/filings/0001110803-26-000024.md) | [409](/filings/0001110803-25-000046.md) | [391](/filings/0001110803-25-000060.md) | [335](/filings/0001110803-25-000073.md) | [376 d](/filings/0001110803-26-000024.md) | [358](/filings/0001110803-26-000092.md) | [364](/filings/0001110803-26-000160.md) | [351](/filings/0001110803-25-000073.md) | [400 d](/filings/0001110803-26-000024.md) | [370](/filings/0001110803-26-000092.md) | [389](/filings/0001110803-26-000160.md) |
| Gross profit | $m | [684](/filings/0001110803-24-000052.md) | [674 d](/filings/0001110803-26-000024.md) | [667](/filings/0001110803-25-000046.md) | [721](/filings/0001110803-25-000060.md) | [745](/filings/0001110803-25-000073.md) | [728 d](/filings/0001110803-26-000024.md) | [683](/filings/0001110803-26-000092.md) | [695](/filings/0001110803-26-000160.md) | [733](/filings/0001110803-25-000073.md) | [759 d](/filings/0001110803-26-000024.md) | [721](/filings/0001110803-26-000092.md) | [770](/filings/0001110803-26-000160.md) |
| Research and development | $m | [315](/filings/0001110803-24-000052.md) | [341 d](/filings/0001110803-26-000024.md) | [339](/filings/0001110803-25-000046.md) | [325](/filings/0001110803-25-000060.md) | [253](/filings/0001110803-25-000073.md) | [256 d](/filings/0001110803-26-000024.md) | [252](/filings/0001110803-26-000092.md) | [247](/filings/0001110803-26-000160.md) | [229](/filings/0001110803-25-000073.md) | [239 d](/filings/0001110803-26-000024.md) | [240](/filings/0001110803-26-000092.md) | [252](/filings/0001110803-26-000160.md) |
| Selling, general and administrative | $m | [303](/filings/0001110803-24-000052.md) | [485 d](/filings/0001110803-26-000024.md) | [439](/filings/0001110803-25-000046.md) | [147](/filings/0001110803-25-000060.md) | [239](/filings/0001110803-25-000073.md) | [279 d](/filings/0001110803-26-000024.md) | [267](/filings/0001110803-26-000092.md) | [234](/filings/0001110803-26-000160.md) | [277](/filings/0001110803-25-000073.md) | [309 d](/filings/0001110803-26-000024.md) | [272](/filings/0001110803-26-000092.md) | [273](/filings/0001110803-26-000160.md) |
| Operating income | $m | [(754)](/filings/0001110803-24-000052.md) | [(164) d](/filings/0001110803-26-000024.md) | [(111)](/filings/0001110803-25-000046.md) | [(1,637)](/filings/0001110803-25-000060.md) | [741](/filings/0001110803-25-000073.md) | [175 d](/filings/0001110803-26-000024.md) | [164](/filings/0001110803-26-000092.md) | [214](/filings/0001110803-26-000160.md) | [227](/filings/0001110803-25-000073.md) | [201 d](/filings/0001110803-26-000024.md) | [209](/filings/0001110803-26-000092.md) | [245](/filings/0001110803-26-000160.md) |
| Interest expense | $m | [19.0](/filings/0001110803-23-000086.md) | [18.0 d](/filings/0001110803-24-000010.md) | [18.0](/filings/0001110803-24-000024.md) | [20.0](/filings/0001110803-25-000060.md) | [36.0](/filings/0001110803-25-000073.md) | [25.0 d](/filings/0001110803-26-000024.md) | [25.0](/filings/0001110803-26-000092.md) | [25.0](/filings/0001110803-26-000160.md) | [25.0](/filings/0001110803-25-000073.md) | [26.0 d](/filings/0001110803-26-000024.md) | [24.0](/filings/0001110803-26-000092.md) | [24.0](/filings/0001110803-26-000160.md) |
| Income tax | $m | [(28.0)](/filings/0001110803-24-000052.md) | [8.0 d](/filings/0001110803-26-000024.md) | [17.0](/filings/0001110803-25-000046.md) | [12.0](/filings/0001110803-25-000060.md) | [15.0](/filings/0001110803-25-000073.md) | [0.0 d](/filings/0001110803-26-000024.md) | [51.0](/filings/0001110803-26-000092.md) | [71.0](/filings/0001110803-26-000160.md) | [70.0](/filings/0001110803-25-000073.md) | [43.0 d](/filings/0001110803-26-000024.md) | [23.0](/filings/0001110803-26-000092.md) | [53.0](/filings/0001110803-26-000160.md) |
| Net income | $m | [(754)](/filings/0001110803-24-000052.md) | [(176)](/filings/0001110803-24-000052.md) | [(126)](/filings/0001110803-25-000073.md) | [(1,988)](/filings/0001110803-25-000073.md) | [705](/filings/0001110803-25-000073.md) | [186](/filings/0001110803-25-000073.md) | [131](/filings/0001110803-26-000160.md) | [235](/filings/0001110803-26-000160.md) | [150](/filings/0001110803-26-000160.md) | [334](/filings/0001110803-26-000160.md) | [134](/filings/0001110803-26-000160.md) | [207](/filings/0001110803-26-000160.md) |
| Diluted EPS | $ per share | [(4.77)](/filings/0001110803-24-000052.md) | not reported | [(0.79)](/filings/0001110803-25-000046.md) | [(12.48)](/filings/0001110803-25-000060.md) | [4.42](/filings/0001110803-25-000073.md) | not reported | [0.82](/filings/0001110803-26-000092.md) | [1.49](/filings/0001110803-26-000160.md) | [0.98](/filings/0001110803-25-000073.md) | not reported | [0.87](/filings/0001110803-26-000092.md) | [1.35](/filings/0001110803-26-000160.md) |
| Basic EPS | $ per share | [(4.77)](/filings/0001110803-24-000052.md) | not reported | [(0.79)](/filings/0001110803-25-000046.md) | [(12.48)](/filings/0001110803-25-000060.md) | [4.43](/filings/0001110803-25-000073.md) | not reported | [0.83](/filings/0001110803-26-000092.md) | [1.49](/filings/0001110803-26-000160.md) | [0.98](/filings/0001110803-25-000073.md) | not reported | [0.88](/filings/0001110803-26-000092.md) | [1.37](/filings/0001110803-26-000160.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $bn | [2.5](/filings/0001110803-23-000086.md) | [2.6](/filings/0001110803-25-000019.md) | [2.6](/filings/0001110803-24-000024.md) | [2.5](/filings/0001110803-24-000044.md) | [2.4](/filings/0001110803-24-000052.md) | [2.7](/filings/0001110803-26-000024.md) | [2.7](/filings/0001110803-25-000046.md) | [2.6](/filings/0001110803-25-000060.md) | [2.8](/filings/0001110803-25-000073.md) | [3.3](/filings/0001110803-26-000160.md) | [2.7](/filings/0001110803-26-000092.md) | [2.8](/filings/0001110803-26-000160.md) |
| Total assets | $bn | [10.1](/filings/0001110803-23-000086.md) | [10.1](/filings/0001110803-25-000019.md) | [10.0](/filings/0001110803-24-000024.md) | [6.1](/filings/0001110803-24-000044.md) | [6.0](/filings/0001110803-24-000052.md) | [6.3](/filings/0001110803-26-000024.md) | [6.2](/filings/0001110803-25-000046.md) | [6.1](/filings/0001110803-25-000060.md) | [6.2](/filings/0001110803-25-000073.md) | [6.6](/filings/0001110803-26-000160.md) | [6.6](/filings/0001110803-26-000092.md) | [6.7](/filings/0001110803-26-000160.md) |
| Current liabilities | $bn | [1.5](/filings/0001110803-23-000086.md) | [1.6](/filings/0001110803-25-000019.md) | [1.5](/filings/0001110803-24-000024.md) | [2.2](/filings/0001110803-24-000044.md) | [1.0](/filings/0001110803-24-000052.md) | [1.5](/filings/0001110803-26-000024.md) | [1.4](/filings/0001110803-25-000046.md) | [1.5](/filings/0001110803-25-000060.md) | [2.0](/filings/0001110803-25-000073.md) | [1.6](/filings/0001110803-26-000160.md) | [1.6](/filings/0001110803-26-000092.md) | [1.6](/filings/0001110803-26-000160.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [5.9](/filings/0001110803-24-000052.md) | [5.7](/filings/0001110803-26-000024.md) | [5.7](/filings/0001110803-25-000073.md) | [1.4](/filings/0001110803-25-000073.md) | [2.1](/filings/0001110803-25-000073.md) | [2.4](/filings/0001110803-26-000160.md) | [2.4](/filings/0001110803-26-000160.md) | [2.3](/filings/0001110803-26-000160.md) | [2.4](/filings/0001110803-26-000160.md) | [2.7](/filings/0001110803-26-000160.md) | [2.7](/filings/0001110803-26-000160.md) | [2.8](/filings/0001110803-26-000160.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [139 d](/filings/0001110803-24-000052.md) | [224 d](/filings/0001110803-26-000024.md) | [77.0](/filings/0001110803-25-000046.md) | [80.0 d](/filings/0001110803-25-000060.md) | [316 d](/filings/0001110803-25-000073.md) | [364 d](/filings/0001110803-26-000024.md) | [240](/filings/0001110803-26-000092.md) | [234 d](/filings/0001110803-26-000160.md) | [284 d](/filings/0001110803-25-000073.md) | [321 d](/filings/0001110803-26-000024.md) | [289](/filings/0001110803-26-000092.md) | [201 d](/filings/0001110803-26-000160.md) |
| Capital expenditure | $m | [45.0 d](/filings/0001110803-24-000052.md) | [51.0 d](/filings/0001110803-26-000024.md) | [36.0](/filings/0001110803-25-000046.md) | [31.0 d](/filings/0001110803-25-000060.md) | [32.0 d](/filings/0001110803-25-000073.md) | [29.0 d](/filings/0001110803-26-000024.md) | [32.0](/filings/0001110803-26-000092.md) | [30.0 d](/filings/0001110803-26-000160.md) | [31.0 d](/filings/0001110803-25-000073.md) | [55.0 d](/filings/0001110803-26-000024.md) | [38.0](/filings/0001110803-26-000092.md) | [40.0 d](/filings/0001110803-26-000160.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001110803-26-000024.md) | [0.0](/filings/0001110803-25-000046.md) | [0.0 d](/filings/0001110803-25-000060.md) | [99.0 d](/filings/0001110803-25-000073.md) | [17.0 d](/filings/0001110803-26-000024.md) | [200](/filings/0001110803-26-000092.md) | [370 d](/filings/0001110803-26-000160.md) | [130 d](/filings/0001110803-25-000073.md) | [42.0 d](/filings/0001110803-26-000024.md) | [242](/filings/0001110803-26-000092.md) | [128 d](/filings/0001110803-26-000160.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-02) | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [157](/filings/0001110803-23-000086.md) | [158](/filings/0001110803-24-000024.md) | [158](/filings/0001110803-24-000044.md) | [158](/filings/0001110803-24-000052.md) | [159](/filings/0001110803-25-000046.md) | [159](/filings/0001110803-25-000060.md) | [160](/filings/0001110803-25-000073.md) | [159](/filings/0001110803-26-000092.md) | [157](/filings/0001110803-26-000160.md) | [154](/filings/0001110803-25-000073.md) | [154](/filings/0001110803-26-000092.md) | [153](/filings/0001110803-26-000160.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 151,000,000 at 2026-07-24, from the cover of the [10-Q filed 2026-07-31](/filings/0001110803-26-000160.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.